By the Numbers

Amerigroup Stock Action During Earnings

Amerigroup will release second-quarter figures on Friday before the bell. Shares of the managed healthcare company are up 110 percent in the past year, compared to an 18 percent gain for the S&P 500.

Based on the last seven earnings reports, LIM's EarningsEdge, a Morningstar company, indicates that Amerigroup has shown a strong bullish edge that peaks 16 trading days before the announcement and a strong bullish edge that peaks 13 trading days after earnings are released.

The current consensus First Call EPS estimate stands at $1.12 versus a gain of $1.31, while revenue is expected to come in at $1.56 billion, compared to $1.44 billion during the same period last year.

What follows are some facts and figures on how the company's shares traded in the most recent earnings reports. 


  • Beat revenue estimates in 5 of the last 8 quarters

  • Beat EPS estimates for 6 consecutive quarters, missed the previous 2

  • Beat annual EPS estimates for 3 consecutive years

  • In 2010, 100 percent of revenue derived from the United States

  • Amerigroup shares closed at an all-time high of $74.87 on July 6, 2011

  • Short-interest as a percent of float stands at 10.9 percent
  • According to Thomson Reuters estimates, the mean price target among 15 financial analysts is $71.27

Competitors' Performance so far in 2011:

  • United Healthgroup , up 39 percent
  • Express Scripts , down 0.06 percent
  • Coventry Health Care , up 32 percent
  • WellCare Health Plans , up 59 percent
  • Centene , up 39 percent

Amerigroup shares are up 54 percent year-to-date.

Stock Performance By The Numbers

  • In the past 8 quarters, Amerigroup shares rose 2.34 percent, on average, thirteen days after the company reported its quarterly results

S&P Health CareSector:

  • Second best performing sector so far in 2011, up 9 percent
  • The top performing stock in this sector is Biogen with a gain of 53 percent
  • Amerigroup is not part of the S&P 500 index

Source: CNBC Analytics, LIM and Thomson Reuters

For more information visit Earnings Central

Comments?  Suggestions? Send them to